{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:57:24Z","timestamp":1761490644890,"version":"3.37.3"},"reference-count":26,"publisher":"European Respiratory Society (ERS)","issue":"4","funder":[{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","award":["TBVAC2020 643381"],"award-info":[{"award-number":["TBVAC2020 643381"]}],"id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["GLOBVAC 248042\/H10"],"award-info":[{"award-number":["GLOBVAC 248042\/H10"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,10,2]]},"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1183\/13993003.01616-2018","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T07:26:42Z","timestamp":1540452402000},"page":"1801616","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk\u00a0of\u00a0tuberculosis"],"prefix":"10.1183","volume":"52","author":[{"given":"Morten","family":"Ruhwald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-7709","authenticated-orcid":false,"given":"Roland","family":"Diel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"2024101909594299000_52.4.1801616.1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3157"},{"key":"2024101909594299000_52.4.1801616.2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00034-13"},{"key":"2024101909594299000_52.4.1801616.3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152"},{"key":"2024101909594299000_52.4.1801616.4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901720106"},{"key":"2024101909594299000_52.4.1801616.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02742-2"},{"key":"2024101909594299000_52.4.1801616.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70210-9"},{"key":"2024101909594299000_52.4.1801616.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-1134OC"},{"key":"2024101909594299000_52.4.1801616.8","unstructured":"Boehme C , Churchyard G , Cobelens F , et\u00a0al. Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease. www.finddx.org\/wp-content\/uploads\/2017\/10\/TPP-framework-for-evaluation-test-predicting-progression-from-TB-active-disease_2017.pdf. Date last updated: 2017. Date last accessed: August 21, 2018."},{"key":"2024101909594299000_52.4.1801616.9","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.lpm.2017.01.015","article-title":"Tuberculosis elimination and the challenge of latent tuberculosis","volume":"46","author":"Matteelli","year":"2017","journal-title":"La Presse M\u00e9dicale"},{"key":"2024101909594299000_52.4.1801616.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104875"},{"key":"2024101909594299000_52.4.1801616.11","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0437"},{"key":"2024101909594299000_52.4.1801616.12","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00021-18"},{"key":"2024101909594299000_52.4.1801616.13","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.69"},{"key":"2024101909594299000_52.4.1801616.14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-2600(16)30419-2","article-title":"From latent to patent: rethinking prediction of tuberculosis","volume":"5","author":"Cobelens","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101909594299000_52.4.1801616.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00946-2018"},{"key":"2024101909594299000_52.4.1801616.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01316-1"},{"key":"2024101909594299000_52.4.1801616.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01012-2016"},{"key":"2024101909594299000_52.4.1801616.18","doi-asserted-by":"crossref","unstructured":"Winje BA , White R , Syre H , et\u00a0al. Stratification by interferon-\u03b3 release assay level predicts risk of incident TB. Thorax 2018; in press [https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211147].","DOI":"10.1136\/thoraxjnl-2017-211147"},{"key":"2024101909594299000_52.4.1801616.19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101909594299000_52.4.1801616.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2007.03.004"},{"key":"2024101909594299000_52.4.1801616.21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","article-title":"Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon \u03b3 release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial","volume":"5","author":"Ruhwald","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101909594299000_52.4.1801616.22","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with M. tuberculosis","volume":"43","author":"Chegou","year":"2013","journal-title":"Eur Respir J"},{"key":"2024101909594299000_52.4.1801616.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015153108"},{"key":"2024101909594299000_52.4.1801616.24","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1038\/srep45969","article-title":"Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6","volume":"7","author":"Ruhwald","year":"2017","journal-title":"Sci Rep"},{"key":"2024101909594299000_52.4.1801616.25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"2024101909594299000_52.4.1801616.26","doi-asserted-by":"crossref","unstructured":"Van Der Meeren O , Hatherill M , Nduba V. Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 2018; in press [http:\/\/dx.doi.org\/10.1056\/NEJMoa1803484].","DOI":"10.1056\/NEJMoa1803484"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01616-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:00:29Z","timestamp":1740380429000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01616-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,25]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1183\/13993003.01616-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01616-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}